RESUMEN
There have been numerous recent inquiries regarding use of hyperbaric oxygen (HBO2) for patients with COVID-19. Questions have been raised pertinent to two possible mechanisms for HBO2 in this clinical context. The UHMS Hyperbaric Oxygen Therapy Committee, UHMS Executive Committee, with collaborative input from multiple senior UHMS members and researchers have drafted this position statement.
Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/terapia , Oxigenoterapia Hiperbárica , Neumonía Viral/terapia , COVID-19 , Ensayos Clínicos como Asunto , Infecciones por Coronavirus/complicaciones , Humanos , Oxigenoterapia Hiperbárica/efectos adversos , Oxigenoterapia Hiperbárica/métodos , Hipoxia/etiología , Hipoxia/terapia , Pandemias , Neumonía/etiología , Neumonía/terapia , Neumonía Viral/complicaciones , SARS-CoV-2 , Sociedades MédicasRESUMEN
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in the prevention of COVID-19 infection or transmission. Within each recommendation, the patient population of interest is specified.